Intravenous Ondansetron and the QT Interval in Adult Emergency Department Patients: An Observational Study

Abstract

Objectives: Ondansetron is known to cause QT interval prolongation, but this effect and clinical significance has not been prospectively studied in adult emergency department (ED) patients. The primary objective was to determine the mean maximal corrected QT interval (QTc) prolongation after intravenous (IV) administration of 4 mg of ondansetron. The secondary objective was to report any serious adverse cardiac electrical events.Methods: This was a prospective, observational, single-center cohort study conducted between 2012 and 2013 in an academic, military hospital ED. Adult patients ordered to receive 4 mg of IV ondansetron were eligible for the study. A six-lead electrocardiogram was recorded at baseline and every 2 minutes after ondansetron administration for 20 minutes. The QTc was calculated using the Bazett formula. Serious adverse cardiac electrical events (nonsinus rhythm, severe bradycardia, and sudden cardiac death) were also recorded.Results: Twenty-two adult ED patients were enrolled. Ondansetron caused a mean prolongation of the QTc by 20 ms (95% confidence interval [CI] = 14 to 26 ms), with a mean proportion change from baseline of 5.2% (95% CI = 3.8% to 6.6%). There were zero (95% CI = 0 to 13%) reported serious adverse cardiac electrical events.

Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma

“…Although there is no evidence‐based recommendation for the management of nausea induced by cabozantinib, metoclopramide and ondansetron used for the management of nausea with cytotoxic chemotherapy could be used in this setting. The potential effects of ondansetron on QT prolongation and the potential drug interaction between cabozantinib and ondansetron should be considered . Marijuana drops for nausea could also be considered .…”

Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

“…Antiemetics such as metoclopramide, levosulpiride or ondansetron may alleviate symptoms. Ondansetron should be used with caution, as it may cause QT prolongation, which is also an AE that can arise with sorafenib, cabozantinib and lenvatinib therapy [49,[60][61][62][63][64]. Based on limited clinical experience from one centre, other pharmacological treatments that may be useful include the analgesic fentanyl and the anti-diarrhoea agent racecadotril [63].…”

Psychopharmacological advances in eating disorders

“…The serotonergic drug ondansetron showed a positive effect in several RCTs such as an RCT performed by Faris et al [141], but cannot be recommended as an off-label indication for BN due to the risk of a dose-dependent prolongation of the QTc interval [142]. Naltrexone an antagonists at the μ-opioid receptor, the κ-opioid receptor and the δ-opioid receptor [143] has shown inconsistent results in BN, and the studies performed so far have low statistical power [23].…”